Aleksandra Siekierska1, Mala Isrie1, Yue Liu1, Chloë Scheldeman1, Niels Vanthillo1, Lieven Lagae1, Peter A M de Witte1, Hilde Van Esch1, Mitchell Goldfarb1, Gunnar M Buyse2. 1. From the Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences (A.S., C.S., N.V., P.A.M.d.W.), and Laboratory for the Genetics of Cognition (M.I.), University of Leuven; Center for Human Genetics (M.I., H.V.E.) and Child Neurology (L.L., G.M.B.), University Hospitals Leuven; Department of Biological Sciences (Y.L., M.G.), Hunter College of City University, New York; and Graduate Program in Biology/Neuroscience at City University (Y.L.), New York, NY. 2. From the Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences (A.S., C.S., N.V., P.A.M.d.W.), and Laboratory for the Genetics of Cognition (M.I.), University of Leuven; Center for Human Genetics (M.I., H.V.E.) and Child Neurology (L.L., G.M.B.), University Hospitals Leuven; Department of Biological Sciences (Y.L., M.G.), Hunter College of City University, New York; and Graduate Program in Biology/Neuroscience at City University (Y.L.), New York, NY. gunnar.buyse@uzleuven.be.
Abstract
OBJECTIVE: Voltage-gated sodium channel (Nav)-encoding genes are among early-onset epileptic encephalopathies (EOEE) targets, suggesting that other genes encoding Nav-binding proteins, such as fibroblast growth factor homologous factors (FHFs), may also play roles in these disorders. METHODS: To identify additional genes for EOEE, we performed whole-exome sequencing in a family quintet with 2 siblings with a lethal disease characterized by EOEE and cerebellar atrophy. The pathogenic nature and functional consequences of the identified sequence alteration were determined by electrophysiologic studies in vitro and in vivo. RESULTS: A de novo heterozygous missense mutation was identified in the FHF1 gene (FHF1AR114H, FHF1BR52H) in the 2 affected siblings. The mutant FHF1 proteins had a strong gain-of-function phenotype in transfected Neuro2A cells, enhancing the depolarizing shifts in Nav1.6 voltage-dependent fast inactivation, predicting increased neuronal excitability. Surprisingly, the gain-of-function effect is predicted to result from weaker interaction of mutant FHF1 with the Nav cytoplasmic tail. Transgenic overexpression of mutant FHF1B in zebrafish larvae enhanced epileptiform discharges, demonstrating the epileptic potential of this FHF1 mutation in the affected children. CONCLUSIONS: Our data demonstrate that gain-of-function FHF mutations can cause neurologic disorder, and expand the repertoire of genetic causes (FHF1) and mechanisms (altered Nav gating) underlying EOEE and cerebellar atrophy.
OBJECTIVE: Voltage-gated sodium channel (Nav)-encoding genes are among early-onset epileptic encephalopathies (EOEE) targets, suggesting that other genes encoding Nav-binding proteins, such as fibroblast growth factor homologous factors (FHFs), may also play roles in these disorders. METHODS: To identify additional genes for EOEE, we performed whole-exome sequencing in a family quintet with 2 siblings with a lethal disease characterized by EOEE and cerebellar atrophy. The pathogenic nature and functional consequences of the identified sequence alteration were determined by electrophysiologic studies in vitro and in vivo. RESULTS: A de novo heterozygous missense mutation was identified in the FHF1 gene (FHF1AR114H, FHF1BR52H) in the 2 affected siblings. The mutant FHF1 proteins had a strong gain-of-function phenotype in transfected Neuro2A cells, enhancing the depolarizing shifts in Nav1.6 voltage-dependent fast inactivation, predicting increased neuronal excitability. Surprisingly, the gain-of-function effect is predicted to result from weaker interaction of mutant FHF1 with the Nav cytoplasmic tail. Transgenic overexpression of mutant FHF1B in zebrafish larvae enhanced epileptiform discharges, demonstrating the epileptic potential of this FHF1 mutation in the affected children. CONCLUSIONS: Our data demonstrate that gain-of-function FHF mutations can cause neurologic disorder, and expand the repertoire of genetic causes (FHF1) and mechanisms (altered Nav gating) underlying EOEE and cerebellar atrophy.
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: Hassan Musa; Crystal F Kline; Amy C Sturm; Nathaniel Murphy; Sara Adelman; Chaojian Wang; Haidun Yan; Benjamin L Johnson; Thomas A Csepe; Ahmet Kilic; Robert S D Higgins; Paul M L Janssen; Vadim V Fedorov; Raul Weiss; Christina Salazar; Thomas J Hund; Geoffrey S Pitt; Peter J Mohler Journal: Proc Natl Acad Sci U S A Date: 2015-09-21 Impact factor: 11.205
Authors: Jun-Yang Lou; Fernanda Laezza; Benjamin R Gerber; Maolei Xiao; Kathryn A Yamada; Hali Hartmann; Ann Marie Craig; Jeanne M Nerbonne; David M Ornitz Journal: J Physiol Date: 2005-09-15 Impact factor: 5.182
Authors: Khaled K Abu-Amero; Altaf A Kondkar; Ibrahim A Alorainy; Arif O Khan; Leila A Al-Enazy; Darren T Oystreck; Thomas M Bosley Journal: Ophthalmic Genet Date: 2013-02-01 Impact factor: 1.803
Authors: Ellen K Wittmack; Anthony M Rush; Matthew J Craner; Mitchell Goldfarb; Stephen G Waxman; Sulayman D Dib-Hajj Journal: J Neurosci Date: 2004-07-28 Impact factor: 6.167
Authors: Vikram G Shakkottai; Maolei Xiao; Lin Xu; Michael Wong; Jeanne M Nerbonne; David M Ornitz; Kelvin A Yamada Journal: Neurobiol Dis Date: 2008-10-01 Impact factor: 5.996
Authors: Marina Trivisano; Alessandro Ferretti; Elizabeth Bebin; Linda Huh; Gaetan Lesca; Aleksandra Siekierska; Ryo Takeguchi; Maryline Carneiro; Luca De Palma; Ilaria Guella; Kazuhiro Haginoya; Ruo Ming Shi; Atsuo Kikuchi; Tomoko Kobayashi; Julien Jung; Lieven Lagae; Mathieu Milh; Marie L Mathieu; Berge A Minassian; Antonio Novelli; Nicola Pietrafusa; Eri Takeshita; Marco Tartaglia; Alessandra Terracciano; Michelle L Thompson; Gregory M Cooper; Federico Vigevano; Laurent Villard; Nathalie Villeneuve; Gunnar M Buyse; Michelle Demos; Ingrid E Scheffer; Nicola Specchio Journal: Epilepsia Date: 2020-07-09 Impact factor: 5.864
Authors: Sameer Al-Mehmadi; Miranda Splitt; Venkateswaran Ramesh; Suzanne DeBrosse; Kimberly Dessoffy; Fan Xia; Yaping Yang; Jill A Rosenfeld; Patrick Cossette; Jacques L Michaud; Fadi F Hamdan; Philippe M Campeau; Berge A Minassian Journal: Neurol Genet Date: 2016-10-28
Authors: Ilaria Guella; Linda Huh; Marna B McKenzie; Eric B Toyota; E Martina Bebin; Michelle L Thompson; Gregory M Cooper; Daniel M Evans; Sarah E Buerki; Shelin Adam; Margot I Van Allen; Tanya N Nelson; Mary B Connolly; Matthew J Farrer; Michelle Demos Journal: Neurol Genet Date: 2016-11-10